Are You Interested in Starting Your Own Health Related Home Based Business? Please Click Here to Find Out How!

Anavex Life Sciences Corp. (”ANAVEX”) (OTCBB: AVXL) announces its participation at the International Conference on Alzheimer’s Disease 2008 (July 26-31, 2008, Chicago, USA), where it will present results obtained with ANAVEX 1-41 demonstrating a protective effect against the neurotoxicity of amyloid (beta)25-35 peptide (A(beta)25-35) in mice.

More: continued here